Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2022. Start Trial.
Date Value
September 30, 2026 135.16M
June 30, 2026 153.07M
March 31, 2026 162.51M
December 31, 2025 176.06M
September 30, 2025 177.31M
June 30, 2025 197.42M
March 31, 2025 207.32M
December 31, 2024 200.93M
September 30, 2024 193.88M
Date Value
June 30, 2024 174.85M
March 31, 2024 158.99M
December 31, 2023 142.72M
September 30, 2023 127.38M
June 30, 2023 108.33M
March 31, 2023 99.08M
December 31, 2022 91.75M
September 30, 2022 79.73M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
EyePoint, Inc. 296.65M
Context Therapeutics, Inc. 37.10M
LENZ Therapeutics, Inc. 0.00
ANI Pharmaceuticals, Inc. 50.60M
Corcept Therapeutics, Inc. 241.72M